Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At ...
Adamis Pharmaceuticals (NASDAQ:ADMP) stock is getting a major boost on Monday thanks to a response from the U.S. Food and Drug Administration (FDA). Source ...
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks ...
The shares of Adamis Pharmaceuticals Corp (NASDAQ:ADMP) have added 11.2% to trade at $2.92 in early market trading, on the U.S. launch of the company's allergy treatment, Symjepi. The drug -- launched ...
Adamis Pharmaceuticals Corp (NASDAQ:ADMP) was on a downward slide for most of the past five years. However, for several months in 2020, and again early in 2021, it came to life. Last year, it peaked ...
Investors in Adamis Pharmaceuticals Corporation ADMP need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 18, 2020 $2.50 Call had some of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results